4D-DIA quantitative proteomics revealed the core mechanism of diabetic retinopathy after berberine treatment

Li Na; Min Xu; Ji-Lin Chen; Guo-Jiao Chen; Jie Sun; Qiang Zhang; Jun-Qi Li; Xi-Liang Guo; Zhong-Fu Zuo; Xue-Zheng Liu; Ting-Hua Wang

doi:10.1016/j.ejphar.2023.175947

4D-DIA quantitative proteomics revealed the core mechanism of diabetic retinopathy after berberine treatment

Eur J Pharmacol. 2023 Nov 5:958:175947. doi: 10.1016/j.ejphar.2023.175947. Epub 2023 Sep 1.

Authors

Li Na¹, Min Xu², Ji-Lin Chen³, Guo-Jiao Chen⁴, Jie Sun⁵, Qiang Zhang⁶, Jun-Qi Li⁷, Xi-Liang Guo⁸, Zhong-Fu Zuo⁹, Xue-Zheng Liu¹⁰, Ting-Hua Wang¹¹

Affiliations

¹ Institute of Neuroscience, Kunming Medical University, Kunming, 650500, China. Electronic address: 1398932495@qq.com.
² Department of Anatomy, College of Basic Medicine, Jinzhou Medical University, Jinzhou, 121000, China. Electronic address: 1213890901@qq.com.
³ Animal Center, Kunming Medical University, Kunming, 650500, China. Electronic address: 1457264487@qq.com.
⁴ Animal Center, Kunming Medical University, Kunming, 650500, China. Electronic address: 3186779919@qq.com.
⁵ Institute of Neuroscience, Kunming Medical University, Kunming, 650500, China. Electronic address: 776493969@qq.com.
⁶ Animal Center, Kunming Medical University, Kunming, 650500, China.
⁷ Department of Anatomy, College of Basic Medicine, Jinzhou Medical University, Jinzhou, 121000, China. Electronic address: 775204489@qq.com.
⁸ Department of Anatomy, College of Basic Medicine, Jinzhou Medical University, Jinzhou, 121000, China. Electronic address: 28203031@qq.com.
⁹ Department of Anatomy, College of Basic Medicine, Jinzhou Medical University, Jinzhou, 121000, China. Electronic address: zuozhongfu@jzmu.edu.cn.
¹⁰ Department of Anatomy, College of Basic Medicine, Jinzhou Medical University, Jinzhou, 121000, China. Electronic address: liuxuezheng@jzmu.edu.cn.
¹¹ Institute of Neuroscience, Kunming Medical University, Kunming, 650500, China; Department of Anatomy, College of Basic Medicine, Jinzhou Medical University, Jinzhou, 121000, China; Animal Center, Kunming Medical University, Kunming, 650500, China.

PMID: 37659689
DOI: 10.1016/j.ejphar.2023.175947

Abstract

Objective: To reveal the core mechanism of berberine (BBR) in the treatment of diabetic retinopathy (DR), by using Four-dimensional independent data acquisition (4D-DIA) proteomics combined bioinformatics analysis with experimental validation.

Methods: DR injury model was established by injecting streptozotocin intraperitoneally. At 8 weeks after BBR administration, optical coherence tomography (OTC) photos and Hematoxylin-eosin staining from retina in each group were performed, then the retina was collected for 4D-DIA quantitative proteomics detection. Moreover, difference protein analysis, Gene Ontology (GO) enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway, protein-protein interaction (PPI) network, as well as molecular docking was performed, respectively. In the part of experiment, Western blot (WB) and immunofluorescent staining was used to confirm the change and distribution of carbonic anhydrase 1 (CA1), one of the most important molecules from quantitative PCR detection. Lastly, RNA knockdown was used to determine the crucial role of CA1 in retinal pigment epithelial cells (RPEs) administrated with berberine.

Results: OCT detection showed that the outer nucleus, inner layer and outer accessory layer of RPEs were thinned in DR group, compared with in sham one, while they were thickened after berberine administration, when compared with in DR group. 10 proteins were screened out by using proteomic analysis and Venny cross plot, in which, denn domain containing 1A (DENND1A) and UTP6 small subunit processome component (UTP6) was down-regulated, while ATPase copper transporting alpha (ATP7A), periplakin (PPL), osteoglycin (OGN), nse1 Homolog (NSMCE1), membrane metalloendopeptidase (MME), lim domain only 4 (LMO4), CA1 and fibronectin 1 (FN1) was up-regulated in DR group, and the BBR treatment can effectively reverse their expressions. PPI results showed that 10 proteins shared interactions with each other, but only ATP7A, FN1 and OGN exhibited directly associated with each other. Moreover, we enlarged the linked relation up to 15 genes in network, based on 10 proteins found from proteomics detection, so as to perform deep GO and KEGG analysis. As a result, the most important biological process is involving rRNA processing; the most important cell component is small subunit processor; the most important molecular function is Phospholipid binding; the KEGG pathway was Ribosome biogenesis in eukaryotes. Moreover, molecular docking showed that LMO4, ATP7A, PPL, NSMCE1, MME, CA1 could form a stable molecular binding pattern with BBR. Of these, the mRNA expression of CA1, PPL and ATP7A and the protein level of CA1 was increased in DR, and decreased in BBR group. Lastly, CA1 RNA knockdown confirmed the crucial role of CA1 in RPE administered with BBR.

Conclusion: The present findings confirmed the role of BBR in DR treatment and explained associated molecular network mechanism, in which, CA1 could be considered as a crucial candidate in the protection of RPEs with berberine treatment.

Keywords: Berberine; Diabetic retinopathy; Network pharmacology.